Current trends and future prospects of drug repositioning in gastrointestinal oncology

Area of Science:

• Oncology
• Pharmacology
• Drug Development

Background:

• Gastrointestinal (GI) cancers are a leading cause of cancer deaths globally.
• Current therapeutic strategies face challenges including lengthy development times, high costs, and potential clinical trial failures.
• There is a critical need for more effective treatments with improved prognoses and reduced side effects.

Purpose of the Study:

• To explore drug repurposing (DR) as a viable strategy for treating GI cancers.
• To review existing therapeutic approaches and challenges in GI cancer treatment.
• To provide a comprehensive overview of DR methodologies, research, and examples in GI cancers.

Main Methods:

• Literature review of drug repurposing methodologies.
• Analysis of research efforts and clinical trial data for repurposed drugs in GI cancers.
• Examination of safety and pharmacological data of existing drugs for new therapeutic applications.

Main Results:

• Drug repurposing leverages existing safety and efficacy data, accelerating the development of new cancer therapies.
• Identified examples of repurposed drugs showing potential in treating colorectal, pancreatic, and liver cancers.
• Various DR methodologies have been developed and applied to GI cancer research.

Conclusions:

• Drug repurposing presents a promising and efficient alternative to traditional drug development for GI cancers.
• This approach can potentially improve survival rates and reduce treatment side effects for patients.
• Further research and clinical trials are warranted to fully realize the potential of DR in GI oncology.